These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. Targoff IN, Trieu EP, Miller FW. J Clin Invest; 1993 Jun; 91(6):2556-64. PubMed ID: 8514867 [Abstract] [Full Text] [Related]
7. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions. Hirakata M. Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):444-54. PubMed ID: 18174673 [Abstract] [Full Text] [Related]
10. [Autoantibodies specifically detected in patients with polymyositis/dermatomyositis]. Sato S. Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):85-93. PubMed ID: 16651706 [Abstract] [Full Text] [Related]
11. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. Tarricone E, Ghirardello A, Rampudda M, Bassi N, Punzi L, Doria A. J Immunol Methods; 2012 Oct 31; 384(1-2):128-34. PubMed ID: 22884621 [Abstract] [Full Text] [Related]
12. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Mimori T, Imura Y, Nakashima R, Yoshifuji H. Curr Opin Rheumatol; 2007 Nov 31; 19(6):523-9. PubMed ID: 17917530 [Abstract] [Full Text] [Related]
13. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis. Ceribelli A, Isailovic N, De Santis M, Generali E, Fredi M, Cavazzana I, Franceschini F, Cantarini L, Satoh M, Selmi C. Clin Rheumatol; 2017 Feb 31; 36(2):469-475. PubMed ID: 27761751 [Abstract] [Full Text] [Related]
16. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies]. Sibilia J, Chatelus E, Meyer A, Gottenberg JE, Sordet C, Goetz J. Presse Med; 2010 Oct 31; 39(10):1010-25. PubMed ID: 20655695 [Abstract] [Full Text] [Related]
17. Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition? Lega JC, Cottin V, Fabien N, Thivolet-Béjui F, Cordier JF. J Rheumatol; 2010 May 31; 37(5):1000-9. PubMed ID: 20231208 [Abstract] [Full Text] [Related]
18. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Lega JC, Fabien N, Reynaud Q, Durieu I, Durupt S, Dutertre M, Cordier JF, Cottin V. Autoimmun Rev; 2014 Sep 31; 13(9):883-91. PubMed ID: 24704867 [Abstract] [Full Text] [Related]
19. Immunoserological aspects of idiopathic inflammatory muscle disease. Rozman B, Bozic B, Kos-Golja M, Plesivcnik-Novljan M, Kveder T. Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):722-7. PubMed ID: 11020964 [Abstract] [Full Text] [Related]
20. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody. Kishaba T, McGill R, Nei Y, Ibuki S, Momose M, Nishiyama K, Nagano H, Yamashiro S. J Med Invest; 2018 Aug 25; 65(3.4):251-257. PubMed ID: 30282869 [Abstract] [Full Text] [Related] Page: [Next] [New Search]